Stefan Hacker

Dr. Stefan Hacker

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MKM. Klinger
M. Klinger
SES. Eipeldauer
S. Eipeldauer
SHStefan Hacker
Stefan Hacker
BHB. Herberger
B. Herberger
DTD. Tamandl
D. Tamandl
TGThomas Gruenberger
Thomas Gruenberger

23 February 2010 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MKMarkus Klinger
Markus Klinger
DTDietmar Tamandl
Dietmar Tamandl
SESandra Eipeldauer
Sandra Eipeldauer
SHStefan Hacker
Stefan Hacker
BHBeata Herberger
Beata Herberger
TGThomas Gruenberger
Thomas Gruenberger

1 November 2008 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SKS. Kandutsch
S. Kandutsch
MKM. Klinger
M. Klinger
SHStefan Hacker
Stefan Hacker
FWF. Wrba
F. Wrba
BGB. Gruenberger
B. Gruenberger
TGThomas Gruenberger
Thomas Gruenberger

6 May 2009 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
hendrik jan ankersmithendrik jan ankersmit
hendrik jan ankersmit
KHKonrad Hötzenecker
Konrad Hötzenecker
WDW. Dietl
W. Dietl
ASA. Soleiman
A. Soleiman
RHR. Horvat
R. Horvat
BPB. K. Podesser
B. K. Podesser

1 February 2013 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
HKH.B. Kitzinger
H.B. Kitzinger
TCT. Cakl
T. Cakl
RWR. Wenger
R. Wenger
SHStefan Hacker
Stefan Hacker
OAO.C. Aszmann
O.C. Aszmann
BKB. Karle
B. Karle

22 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Michael MildnerMichael Mildner
Michael Mildner
SHStefan Hacker
Stefan Hacker
THThomas Haider
Thomas Haider
MGMaria Gschwandtner
Maria Gschwandtner
GWGregor Werba
Gregor Werba
hendrik jan ankersmithendrik jan ankersmit
hendrik jan ankersmit
Non-healing skin ulcers are often resistant to most common therapies. Treatment with growth factors has been demonstrated to improve closure of chronic wounds. Here we investigate whether lyophilized culture supernatant of freshly isolated peripheral blood mononuclear cells (PBMC) is able to enhance wound healing. PBMC from healthy human individuals were prepared and cultured for 24 hours. Supernatants were collected, dialyzed and lyophilized (SECPBMC). Six mm punch biopsy wounds were set on the backs of C57BL/6J-mice and SECPBMC containing emulsion or controls were applied daily for three days. Morphology and neo-angiogenesis were analyzed by H&E-staining and CD31 immuno-staining, respectively. In vitro effects on diverse skin cells were investigated by migration assays, cell cycle analysis, and tube formation assay. Signaling pathways were analyzed by Western blot analysis. Application of SECPBMC on 6 mm punch biopsy wounds significantly enhanced wound closure. H&E staining of the wounds after 6 days revealed that wound healing was more advanced after application of SECPBMC containing emulsion. Furthermore, there was a massive increase in CD31 positive cells, indicating enhanced neo-angiogenesis. In primary human fibroblasts (FB) and keratinocytes (KC) migration but not proliferation was induced. In endothelial cells (EC) SECPBMC induced proliferation and tube-formation in a matrigel-assay. In addition, SECPBMC treatment of skin cells led to the induction of multiple signaling pathways involved in cell migration, proliferation and survival. In summary, we could show that emulsions containing the secretome of PBMC derived from healthy individuals accelerates wound healing in a mouse model and induce wound healing associated mechanisms in human primary skin cells. The formulation and use of such emulsions might therefore represent a possible novel option for the treatment of non-healing skin ulcers.